
Market experts have identified five stocks for potential investment on Thursday, November 19, with varying target upside potentials. According to reports from NDTV Profit, the recommendations include Sun TV Network Ltd. (CMP: ₹696.00), Dr Reddy's Laboratories Ltd. (CMP: ₹1,398.20), GAIL (India) Ltd. (CMP: ₹190), Eternal Ltd. (CMP: ₹366), and Adani Power Ltd. (CMP: ₹205.30). The target prices suggest potential gains ranging from 4.21% to 9.29% upside from current market prices.
Deven Mehata, Manager – Technical & Derivatives Analyst at IDBI Capital Market and Securities Ltd., recommends buying Sun TV Network at ₹696 with a target of ₹752 and a stop-loss of ₹668. As reported by NDTV Profit, this target implies 8.05% upside from the current market price. The recommendation comes from IDBI Capital's technical analysis of the stock's price movement patterns.
Deven Mehata also recommends buying Dr Reddy's Laboratories at ₹1,398 with a target of ₹1,510 and a stop-loss of ₹1,345. According to the technical analysis reported by NDTV Profit, this target implies 8.00% upside from the current market price. The recommendation is based on IDBI Capital's technical assessment of the pharmaceutical company's price action.
Osho Krishan, Chief Manager – Technical and Derivative Research at Angel One, recommends buying GAIL at ₹188 with a target of ₹198 and a stop-loss of ₹182. As reported by NDTV Profit, this target implies 4.21% upside from the current market price. Similarly, Krishan recommends buying Adani Power at ₹204 with a target of ₹214 and a stop-loss of ₹198. Both recommendations are based on technical analysis of price movement patterns and support levels.
VLA Ambala, a SEBI-registered research analyst and founder of SMT Stock Market, recommends buying Eternal at ₹320–325 with targets of ₹350 and ₹400 and a stop-loss of ₹290. According to the analysis reported by NDTV Profit, the higher target implies 9.29% upside from the current market price. The recommendation suggests a two-stage approach with the first target representing 4.37% below the CMP, though both targets are above the recommended entry range.